TABLE 1.
Clinicopathological Data of the Cases Included in Study 1 (Evaluation of Photos) and Study 2A and 2B (Evaluation of Scanned Sections)
| Case Nr. | Age | Sex | Neuropathology |
Photo Number and Region |
Scan Number and Region |
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AD/ PART | Braak Stage | Thal Phase | CERAD Score | AGD | ARTAG | PSP | CBD | GGT | Pick's Disease | Frontal Cx | Temporal Cx | Hippocampus | Amygdala | Basal Ganglia | Frontal Cx | Temporal Cx | Ant. cingulate | Hippocampus | Amygdala | Basal ganglia | Mesencephalon | Medulla obl. | |||
| Case-1 | 80 | f | + | 3 | 1 | 1 | + | + | − | − | − | − | 1 | 1 | |||||||||||
| Case-2 | 85 | f | + | 2 | 1 | 1 | − | + | − | − | − | − | 2–5 | 6–10 | 3 | 2 | 4 | 5 | 6 | ||||||
| Case-3 | 87 | f | + | 3 | 1 | 1 | − | + | − | − | − | − | 11,12 | 7 | |||||||||||
| Case-4 | 89 | f | + | 3 | 2 | 1 | + | + | − | − | − | − | 13,14 | 8 | |||||||||||
| Case-5 | 83 | f | + | 6 | 5 | 3 | + | + | +* | − | − | − | 15,16 | 9 | |||||||||||
| Case-6 | 83 | f | + | 3 | 2 | 2 | + | + | − | − | − | − | 17–19 | 10 | |||||||||||
| Case-7 | 85 | m | + | 2 | 1 | 1 | + | + | − | − | − | − | 20 | 11 | |||||||||||
| Case-8 | 77 | m | + | 3 | 2 | 2 | + | + | − | − | − | − | 21 | 12 | 25 | ||||||||||
| Case-9 | 82 | m | + | 5 | 3 | 2 | + | + | + | − | − | − | 22 | 13 | |||||||||||
| Case-10 | 86 | m | + | 5 | 3 | 3 | + | + | − | − | − | − | 23 | 14 | |||||||||||
| Case-11 | 82 | m | + | 3 | 1 | 1 | + | + | − | − | − | − | 24 | 17 | |||||||||||
| Case-12 | 79 | m | + | 4 | 3 | 2 | − | − | − | + | − | − | 25, 28, 30 | 16 | |||||||||||
| Case-13 | 76 | f | + | 2 | 0 | 0 | − | +† | + | – | − | − | 26,27,29 | 19 | |||||||||||
| Case-14 | 88 | f | + | 4 | 3 | 3 | + | + | − | − | − | − | 31 | 22 | |||||||||||
| Case-15 | 63 | f | − | − | − | − | − | − | − | − | + | − | 32,34 | ||||||||||||
| Case-16 | 55 | m | − | − | − | − | − | − | − | − | − | + | 33 | ||||||||||||
| Case-17 | 65 | f | − | − | − | − | − | − | − | − | − | + | 35 | ||||||||||||
| Case-18 | 82 | f | + | 2 | 1 | 1 | − | + | − | − | − | − | 15 | ||||||||||||
| Case-19 | 87 | f | + | 3 | 0 | 0 | + | + | +* | − | − | − | 18 | 23 | |||||||||||
| Case-20 | 85 | m | + | 1 | 0 | 0 | − | + | − | − | − | − | 20 | ||||||||||||
| Case-21 | 81 | m | + | 1 | 0 | 0 | − | +† | − | − | − | − | 21 | ||||||||||||
| Case-22 | 83 | m | + | 2 | 1 | 1 | + | + | − | − | − | − | 24 | ||||||||||||
m, male; f, female; CERAD, Consortium to Establish a Registry for Alzheimer Disease; Cx, cortex. Braak stage refers to neurofibrillary degeneration (34) and Thal phase to Aβ deposition (35).
*
Indicates that presence of subcortical neurofibrillary tangles were suggestive of early form of PSP.
†
Indicates that ARTAG was represented by occasional GFA.